Goldman Sachs’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-29,598
| Closed | -$39K | – | 5318 |
|
|
2022
Q3 | $39K | Sell |
29,598
-58,756
| -67% | -$77.4K | ﹤0.01% | 5060 |
|
|
2022
Q2 | $196K | Buy |
88,354
+26,753
| +43% | +$59.3K | ﹤0.01% | 4911 |
|
|
2022
Q1 | $381K | Sell |
61,601
-61,681
| -50% | -$381K | ﹤0.01% | 4749 |
|
|
2021
Q4 | $1.56M | Buy |
123,282
+82,441
| +202% | +$1.04M | ﹤0.01% | 3680 |
|
|
2021
Q3 | $3.74M | Buy |
40,841
+16,285
| +66% | +$1.49M | ﹤0.01% | 2990 |
|
|
2021
Q2 | $1.3M | Buy |
24,556
+3,877
| +19% | +$206K | ﹤0.01% | 3833 |
|
|
2021
Q1 | $745K | Sell |
20,679
-27,810
| -57% | -$1M | ﹤0.01% | 4110 |
|
|
2020
Q4 | $1.35M | Buy |
48,489
+10,401
| +27% | +$289K | ﹤0.01% | 3294 |
|
|
2020
Q3 | $1.9M | Sell |
38,088
-578
| -1% | -$28.9K | ﹤0.01% | 2934 |
|
|
2020
Q2 | $1.79M | Buy |
+38,666
| New | +$1.79M | ﹤0.01% | 2893 |
|
|
2020
Q1 | – | Sell |
-7,895
| Closed | -$443K | – | 4535 |
|
|
2019
Q4 | $443K | Sell |
7,895
-165
| -2% | -$9.26K | ﹤0.01% | 3704 |
|
|
2019
Q3 | $201K | Sell |
8,060
-40,070
| -83% | -$999K | ﹤0.01% | 3915 |
|
|
2019
Q2 | $2.05M | Buy |
+48,130
| New | +$2.05M | ﹤0.01% | 2803 |
|